AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

ERFURT and BERLIN, Germany – September 28th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX) (“AMP”), a pharmaceutical supplier of medical and CBD therapeutic wellness cannabis…

Continue ReadingAMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

AMP and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

ERFURT / BERLIN and STADTBERGEN, Germany – September 13th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German…

Continue ReadingAMP and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

AMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany’s Largest Cancer Convention

ERFURT / BERLIN, Germany – September 8th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of cosmetic CBD cannabis products to German pharmacies,…

Continue ReadingAMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany’s Largest Cancer Convention

AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany

ERFURT and BERLIN, Germany, April 7th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment…

Continue ReadingAMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany

AMP Alternative Medical Products Closes Oversubscribed Non-Brokered Private Placement

ERFURT and BERLIN, Germany, February 10th, 2021, AMP Alternative Medical Products Inc. (Formerly AMP German Cannabis Group Inc.) (“AMP”) (CSE: XCX), (Frankfurt: C4TA, ISIN: CA0318961038), a licenced importer of medical…

Continue ReadingAMP Alternative Medical Products Closes Oversubscribed Non-Brokered Private Placement

AMP German Cannabis Group Changes Company Name to AMP Alternative Medical Products

ERFURT / BERLIN, Germany, January 29th, 2021 – AMP German Cannabis Group Inc. (“AMP” and or “the Company”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces that it has changed its…

Continue ReadingAMP German Cannabis Group Changes Company Name to AMP Alternative Medical Products

AMP German Cannabis Group and Aphria’s subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany

ERFURT / BERLIN / DENSBORN, Germany, and LEAMINGTON, Ontario, Canada – January 26th, 2021– AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) and Aphria Inc.’s (“Aphria”)…

Continue ReadingAMP German Cannabis Group and Aphria’s subsidiary CC Pharma GmbH enter into Strategic Co-Promotion Agreement for the Sale of Medical Cannabis in Germany